Controlled substances covered by the rule include stimulant medicines for attention-deficit/hyperactivity disorder, anxiety medications and medications for opioid use disorder. The extension is designed to give time to patients who have come to rely on telehealth and allow providers to get compliant.
Prior to the COVID-19 pandemic, patients needed at least one in-person visit to receive controlled substances. In February, the DEA proposed rolling back the COVID-19 era flexibility but faced backlash from telehealth groups.
Telehealth groups have continued to push the agency to create a registration pathway for remote prescriptions
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
